Clinical Trials Rare diseases: how can decentralisation speed up trials and reduce patient burden? 26 Feb 2021
Alkahest doses first patient in Phase II Parkinson’s drug trial Alkahest has dosed the first subject in a Phase II clinical trial of GRF6021 to... 6th December 2018